[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555650":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":34,"collaborators":10,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":10,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":10,"studyType":51,"phases":10,"briefSummary":52,"conditions":53,"keywords":10,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"Sohag University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients Group",null,"Study Population:\n\nPlace of study: Participants will be recruited from the diabetes clinic, Sohag university hospital.\n\nType of the study: Cross-Sectional Comparative study.\n\nPatients:\n\nv Study group: participants of the study will meet the following criteria:\n\nØ Inclusion criteria:\n\nü Age: 30-55 y\n\nü Type of diabetes: Type 2\n\nü Duration of diabetes: Within 1 Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria\n\nü Gender: Both males \\& females\n\nØ Exclusion criteria:\n\nPatients who had known conditions that could present with neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplastic conditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Reda Khalaf Allah Khalil, Resident","CONTACT","0102 006 5913","redakhalaf@med.sohag.edu.eg",[19],{"facility":20,"status":21,"city":22,"state":10,"zip":10,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Faculty of medecine Sohag university","RECRUITING","Sohag","Egypt","EG",{"type":26,"coordinates":27},"Point",[28,29],31.69478,26.55695,{"lat":29,"lon":28},[32],{"name":33,"role":15,"phone":16,"phoneExt":10,"email":17},"Reda Khalil, Resident",{"type":35,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Reda Khalafallah Khalil","Principal investigator","100555650","utilizing-the-michigan-neuropathy-screening-instrument-for-early-detection-of-diabetic-neuropathy-100555650",false,"NCT06514846","Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy","Utilizing the Michigan Neuropathy Screening Instrument, Routine Nerve Conduction Study (NCS), and Nerve Ultrasound for Early Detection of Diabetic Neuropathy","Inclusion Criteria:\n\n* ü Age: 30-55 y\n\nü Type of diabetes: Type 2\n\nü Duration of diabetes: Within 1Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria\n\nExclusion Criteria:\n\n* Patients who had known conditions that could present with neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplastic conditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.","ALL","33 Years","65 Years",{"count":49,"type":50},100,"ESTIMATED","OBSERVATIONAL","The study aims to Compare the diagnostic accuracy of the Michigan Neuropathy Screening Instrument (MNSI) (using MNS questionnaire, ,Inspection, vibratory sensation, Ankle reflexes Exam, 10 g monofilament needle examination), routine NCS, and the U\u002FS of the median, posterior tibial, and sural nerves in identifying diabetic peripheral neuropathy in patients recently diagnosed with type 2 diabetes.",[54],"Diabetic Polyneuropathy","2024-07-27",{"date":57,"type":58},"2024-07-30","ACTUAL",{"date":60,"type":58},"2023-06-01",{"date":62,"type":50},"2025-06-01",{"name":5,"class":6},1]